| 000 | 01777 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250518001657.0 | ||
| 264 | 0 | _c20181016 | |
| 008 | 201810s 0 0 eng d | ||
| 022 | _a1536-5964 | ||
| 024 | 7 |
_a10.1097/MD.0000000000012464 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhang, Kaiyan | |
| 245 | 0 | 0 |
_aPeriocular triamcinolone acetonide injection for treating polypoidal choroidal vasculopathy concurrent with hemorrhagic retinal detachment. _h[electronic resource] |
| 260 |
_bMedicine _cSep 2018 |
||
| 300 |
_ae12464 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Observational Study | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aChoroid _xblood supply |
| 650 | 0 | 4 |
_aChoroid Diseases _xdiagnostic imaging |
| 650 | 0 | 4 |
_aChoroidal Neovascularization _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlucocorticoids _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInjections, Intraocular _xmethods |
| 650 | 0 | 4 | _aIntravitreal Injections |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aRetinal Detachment _xdrug therapy |
| 650 | 0 | 4 |
_aRetinal Hemorrhage _xcomplications |
| 650 | 0 | 4 |
_aTomography, Optical Coherence _xmethods |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTriamcinolone Acetonide _xadministration & dosage |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aVisual Acuity _xdrug effects |
| 700 | 1 | _aChen, Yingying | |
| 700 | 1 | _aSun, Xuyang | |
| 700 | 1 | _aZhong, Qionglei | |
| 700 | 1 | _aLin, Lin | |
| 700 | 1 | _aGao, Yuan | |
| 700 | 1 | _aHong, Fanlin | |
| 773 | 0 |
_tMedicine _gvol. 97 _gno. 39 _gp. e12464 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/MD.0000000000012464 _zAvailable from publisher's website |
| 999 |
_c28897290 _d28897290 |
||